These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 14328796)
1. NORETHYNODREL AND MESTRANOL (ENAVID) IN THE PREVENTION OF RECURRENT ABORTION. MACDONALD RR Lancet; 1965 Aug; 2(7408):362-4. PubMed ID: 14328796 [No Abstract] [Full Text] [Related]
2. REGRESSION RATE OF VASCULAR EFFECTS INDUCED BY PREGNANCY AND BY NORETHYNODREL-MESTRANOL. MANALO-ESTRELLA P; DANFORTH DN; BUCKINGHAM JC Fertil Steril; 1965; 16():81-4. PubMed ID: 14256103 [No Abstract] [Full Text] [Related]
3. SEVERE UTERINE BLEEDING FOLLOWING THE PROLONGED USE OF NORETHYNODREL-MESTRANOL. KAHN S; NOVICK O; DIAMOND S Obstet Gynecol; 1965 Mar; 25():298-301. PubMed ID: 14268008 [No Abstract] [Full Text] [Related]
4. [COLPOSCOPIC, CYTOLOGIC AND HISTOLOGIC FINDINGS IN THE PORTIO UTERI DURING OVULATION INHIBITING MEDICATION]. SOOST HJ Munch Med Wochenschr; 1965 Mar; 107():489-90. PubMed ID: 14269068 [No Abstract] [Full Text] [Related]
5. STUDIES OF HEPATIC EXCRETORY FUNCTION. II. THE EFFECT OF NORETHYNODREL AND MESTRANOL ON BROMSULFALIEN SODIUM METABOLISM IN WOMEN OF CHILDBEARING AGE. Kleiner GJ; Kresch L; Arias IM N Engl J Med; 1965 Aug; 273():420-3. PubMed ID: 14328105 [No Abstract] [Full Text] [Related]
6. The effect of enovid, a synthetic 19-nor-steroid (norethynodrel) on post-menopausal vaginal and uterine mucosa. CRONQVIST M; KULLANDER S Acta Obstet Gynecol Scand; 1961; 40():43-58. PubMed ID: 13696567 [No Abstract] [Full Text] [Related]
9. [EXPERIMENTAL RESEARCH ON AN ASSOCIATION WITH PROGESTERONIC AND ESTROGENIC ACTIVITY]. SARLUCA F; PALMIERI A Arch Ostet Ginecol; 1964; 69():531-51. PubMed ID: 14253211 [No Abstract] [Full Text] [Related]
10. DILATION OF THE VEINS WITH PREGNANCY OR WITH ORAL CONTRACEPTIVE THERAPY. WOOD JE; GOODRICH SM Trans Am Clin Climatol Assoc; 1964; 76():174-80. PubMed ID: 14301914 [No Abstract] [Full Text] [Related]
11. ORAL CONTRACEPTION. BRYANS FE Can Med Assoc J; 1965 Feb; 92(6):287-8. PubMed ID: 14270213 [No Abstract] [Full Text] [Related]
12. TRIAL OF A NEW FORM OF ORAL CONTRACEPTIVE. CARRUTHERS GB Br J Clin Pract; 1965 Aug; 19():455-60. PubMed ID: 14324833 [No Abstract] [Full Text] [Related]
13. THE EXCRETION OF PREGNANEDIOL DURING TREATMENT WITH GESTAGENS (ENAVID) ESTIMATED BY THIN-LAYER-CHROMATOGRAPHY. Berthelsen HG; Bang HO Acta Obstet Gynecol Scand; 1965; 43(S7):45-9. PubMed ID: 14286746 [No Abstract] [Full Text] [Related]
14. Effect of enovid on the human ovary, endometrium and vaginal smears during the preovulatory phase. VASICKA A; RICHTER FJ Surg Forum; 1960; 10():730-3. PubMed ID: 13841402 [No Abstract] [Full Text] [Related]
15. Effects of norethynodrel and mestranol on endometrial and vaginal enzymatic activities in mice. Chang YS; Russfield AB Am J Obstet Gynecol; 1968 Nov; 102(5):736-44. PubMed ID: 5684547 [No Abstract] [Full Text] [Related]
16. ORAL CONTRACEPTIVE HORMONES AND BLOOD COAGULABILITY. THOMSON JM; POLLER L Br Med J; 1965 Jul; 2(5456):270-3. PubMed ID: 14310204 [No Abstract] [Full Text] [Related]
17. OPTIMUM DOSAGE FOR ESTROGEN-PROGESTOGEN BALANCE TO INHIBIT OVULATION. JACKSON MC; LINN R Int J Fertil; 1964; 9():75-86. PubMed ID: 14106271 [No Abstract] [Full Text] [Related]
18. [APROPOS OF A CASE OF THROMBOEMBOLISM APPEARING DURING TREATMENT WITH NORETHYNODREL-MESTRANOL. ATTEMPTED PATHOGENIC INTERPRETATION]. GRASSET J; GAUTHIER R Gynecol Obstet (Paris); 1965; 64():197-214. PubMed ID: 14322503 [No Abstract] [Full Text] [Related]
19. NORETHYNODREL WITH MESTRANOL IN TREATMENT OF RHEUMATOID ARTHRITIS. GILBERT M; ROTSTEIN J; CUNNINGHAM C; ESTRIN I; DAVIDSON A; PINCUS G JAMA; 1964 Oct; 190():235. PubMed ID: 14246596 [No Abstract] [Full Text] [Related]
20. [CLINICAL USE OF A NEW ORAL PROGESTOGEN: CHLORMADINONE]. DELCORRAL F; ARTUZ A; SALCEDO CA; ERAZO JV; ANGEL G Rev Colomb Obstet Ginecol; 1963; 14():605-23. PubMed ID: 14117499 [No Abstract] [Full Text] [Related] [Next] [New Search]